Armani, Dior Face Antitrust Probe in Italy
By Mauro Orru
Italy's competition watchdog launched an investigation into Giorgio Armani and Christian Dior, saying the luxury-goods companies might have resorted to illegal labor practices to produce and sell their high-priced goods.
The Italian Competition Authority, or AGCM, said the companies may have relied on supplies from workshops where laborers receive inadequate wages and work overtime in poor health and safety conditions, while emphasizing the craftsmanship of their goods to promote and sell them to customers.
Armani and LVMH Moet Hennessy Louis Vuitton, which owns Dior, didn't immediately respond to requests for comment.
The probe comes weeks after an investigation by Milan prosecutors found workshops making handbags and other leather goods for Armani and Dior used exploited foreign labor to produce the high-end products at a fraction of their retail price.
The AGCM said antitrust officials had conducted inspections at Armani and Dior premises on Tuesday.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
July 17, 2024 03:09 ET (07:09 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks